Last reviewed · How we verify
Aldosterone Antagonists - spironolactone — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Aldosterone Antagonists - spironolactone (Aldosterone Antagonists - spironolactone) — NHS Greater Glasgow and Clyde.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aldosterone Antagonists - spironolactone TARGET | Aldosterone Antagonists - spironolactone | NHS Greater Glasgow and Clyde | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aldosterone Antagonists - spironolactone CI watch — RSS
- Aldosterone Antagonists - spironolactone CI watch — Atom
- Aldosterone Antagonists - spironolactone CI watch — JSON
- Aldosterone Antagonists - spironolactone alone — RSS
Cite this brief
Drug Landscape (2026). Aldosterone Antagonists - spironolactone — Competitive Intelligence Brief. https://druglandscape.com/ci/aldosterone-antagonists-spironolactone. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing